Biprojit Bhowmick*, Sourav Pal, Koyel Mandal, Dr. Khokan Bera, Saikat Maji and Hiranmoy Bera


Paclitaxel is a broad-spectrum anticancer chemical obtained mostly from medicinal plants, specifically the bark of the yew tree Taxus brevifolia Nutt. It belongs to the diterpene taxanes class, which is today the most often used chemotherapeutic drug against many types of cancer. It has been shown in studies to have anticancer action against ovarian, lung, and breast malignancies. Paclitaxel, a taxane with microtubule stabilising properties, has remained the standard of treatment for primary ovarian cancer management. Taxanes with improved safety profiles and increased intra-tumor cytotoxicity have yet to outperform the original molecule in clinical trials. The mechanisms of PTX action illustrate the various ways in which PTX influences cellular functions, ultimately leading to programmed cell death. In addition, PTX is commonly utilised as a first-line therapy medicine for breast cancer (BC). Factors contributing to PTX resistance, such as ABC transporters, micro-RNAs (miRNAs), or mutations in specific genes, as well as PTX side effects such as peripheral neuropathy or hypersensitivity associated with the vehicle used to overcome its poor solubility, are driving extensive research into PTX use in preclinical and clinical studies.

Keywords: Ovarian cancer, breast cancer, anti-cancer therapy, Paclitaxel, nanomedicine, phytochemicals.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation


    MARCH 2023 Issue has been successfully launched on 1 MARCH 2023.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction